Buying Groups Shook Down Vaccine Customers, Sanofi Says

Law360, New York (February 27, 2012, 7:28 PM ET) -- Sanofi Pasteur Inc. on Monday lashed out at a class action accusing the vaccine maker of pushing anti-competitive contract restrictions onto its customers, claiming that any antitrust activity can be attributed to the use of physician buying groups that negotiate discounted prices for Sanofi vaccines.

Sanofi said in a motion to dismiss filed in New Jersey federal court that it in no way coerced doctors or hospitals to purchase its vaccines, and that any pressure for buyers to exclusively purchase Sanofi vaccines derived from the buying...
To view the full article, register now.